MELAS SYNDROME
Clinical trials for MELAS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MELAS SYNDROME trials appear
Sign up with your email to follow new studies for MELAS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a simple fat compound help treat rare energy disorders?
Disease control Recruiting nowThis study tests an oral drug called glycerol tributyrate in 24 adults with MELAS or LHON-Plus, two rare diseases that affect how cells produce energy. The goal is to find a safe dose and see if it improves daily activity, walking, and reduces hospital visits. Each participant se…
Matched conditions: MELAS SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: George Washington University • Aim: Disease control
Last updated May 26, 2026 08:07 UTC
-
New hope for rare mitochondrial disease: TTI-0102 enters phase 2 trial
Disease control Recruiting nowThis study tests an oral drug called TTI-0102 in 12 people aged 16–60 with MELAS, a rare genetic disorder that causes muscle weakness, lactic acid buildup, and stroke-like episodes. Participants receive either TTI-0102 or a placebo for 6 months to see if the drug improves walking…
Matched conditions: MELAS SYNDROME
Phase: PHASE2 • Sponsor: Thiogenesis Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 07:58 UTC